MALARIA RESEARCH INSTITUTE
Leading Science for a Malaria-Free World
Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.
The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.
Future of Malaria Research Symposium
An event focused on early-career scientists, with opportunities to present new research and network. Registration deadline is October 18.
News and Noteworthy
In the News
A Rare Mosquito-Borne Illness Is On The Rise. Here's What To Know. Matt Ippolito, MD, is quoted.
In the News
Rare, deadly mosquito disease is causing alarm in New England. But how risky is "triple E" virus? David Sullivan, MD, is quoted.
In the News
Why Mosquitoes Are So Dangerous Right Now. Photini Sinnis, MD, is quoted.
Newly Published
Assembled genome of an Ethiopian Plasmodium vivax isolate generated using GridION long-read technology | Carlton Lab
Newly Published
Application of Machine Learning in a Rodent Malaria Model for Rapid, Accurate, and Consistent Parasite Counts | Srinivasan Lab
Newly Published
The major surface protein of malaria sporozoites is GPI-anchored to the plasma membrane | Sinnis Lab
130+
Pilot grants awarded
750+
First- and last-authored publications since 2010